Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.pardrugs.com | |
Market Cap | 272.42 Cr. | |
Enterprise Value(EV) | 272.42 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 10.30 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 21.49 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 37.71 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 63.88 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 3.47 | Calculated using Price: 221.40 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 1.23 Cr. | 12,304,636 Shares |
FaceValue | 10 | |
About Par Drugs And Chemicals Ltd. | ||
PDCL is engaged in the development and manufacture of Active Pharma Ingredients (APIs) for the domestic market as well as for exports to international markets. It currently produce various range of Antacid Molecules which are available in the market and are in great demand. |
1 Day |
|
+2.67% |
1 Week |
|
-6.07% |
1 Month |
|
+3.51% |
3 Month |
|
+19.22% |
6 Month |
|
+7.74% |
1 Year |
|
+40.84% |
2 Year |
|
+16.80% |
5 Year |
|
|
10 Year |
|
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 8.18 | 3.69 | 14.75 | 10.63 | 11.35 | 13.68 | 25.02 | 16.44 | 17.29 | |
Return on Capital Employed (%) | 9.92 | 9.36 | 12.34 | 11.19 | 12.41 | 15.56 | 28.68 | 21.85 | 23.20 | |
Return on Assets (%) | 1.48 | 0.72 | 3.24 | 2.77 | 4.78 | 8.56 | 17.01 | 11.88 | 13.53 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 17 | 17 | 19 | 21 | 29 | 41 | 52 | 60 | 71 | 79 | |
Non Curr. Liab. | 23 | 19 | 17 | 16 | 10 | 9 | 8 | 4 | 4 | 4 | |
Curr. Liab. | 19 | 22 | 20 | 17 | 12 | 11 | 16 | 15 | 14 | 13 | |
Minority Int. | |||||||||||
Equity & Liab. | 59 | 58 | 56 | 54 | 51 | 60 | 76 | 79 | 89 | 96 | |
Non Curr. Assets | 46 | 43 | 42 | 40 | 37 | 36 | 35 | 35 | 39 | 42 | |
Curr. Assets | 13 | 15 | 14 | 14 | 14 | 24 | 41 | 44 | 49 | 54 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 59 | 58 | 56 | 54 | 51 | 60 | 76 | 79 | 89 | 96 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 33 | 33 | 49 | 42 | 46 | 56 | 61 | 75 | 96 | 96 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total Income | 33 | 33 | 49 | 42 | 46 | 56 | 61 | 75 | 96 | 96 | |
Total Expenditure | -26 | -26 | -40 | -34 | -38 | -46 | -45 | -59 | -78 | -76 | |
PBIDT | 8 | 7 | 9 | 8 | 8 | 10 | 16 | 16 | 18 | 20 | |
Interest | -4 | -4 | -3 | -2 | -2 | -1 | -1 | 0 | 0 | 0 | |
Depreciation | -2 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | |
Taxation | 0 | -1 | -1 | -1 | -1 | -1 | -3 | -3 | -4 | -4 | |
Exceptional Items | 2 | ||||||||||
PAT | 1 | 0 | 2 | 2 | 3 | 5 | 12 | 9 | 11 | 13 | |
Adjusted EPS | 2 | 1 | 3 | 3 | 3 | 4 | 9 | 7 | 9 | 10 |
Particulars | 7 years | 2016-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 7 | 5 | 3 | 8 | 12 | 8 | 13 | |
Cash Fr. Inv. | 0 | -1 | 0 | -1 | 0 | -3 | -7 | |
Cash Fr. Finan. | -5 | -4 | -3 | 1 | 2 | -10 | ||
Net Change | 1 | 0 | 0 | 7 | 14 | -5 | 6 | |
Cash & Cash Eqvt | 1 | 0 | 0 | 7 | 21 | 16 | 22 |
Tue, 31 Oct 2023
Copy of Newspaper Publication
|
|
Mon, 30 Oct 2023
Copy of Newspaper Publication
|
|
Fri, 20 Oct 2023
Board Meeting Intimation
|
Fri, 08 Dec 2023 |
|
|
|
|
|